Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | OraSure Technologies, Inc.✕ OSUR · #15,291 in the world |
|---|---|
| Profile | |
| Country | 🇺🇸 USA |
| Sector | Healthcare |
| Industry | Medical Instruments |
| Founded | 1987 |
| Size | |
| Market cap | $262 M |
| Revenue | $115 M |
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | OraSure Technologies, Inc. |
|---|---|
| 2025 | $115 MSEC |
| 2024 | $186 MSEC |
| 2023 | $405 MSEC |
| 2022 | $387 MSEC |
| 2021 | $234 MSEC |
| 2020 | $172 MSEC |
| 2019 | $155 MSEC |
| 2018 | $182 MSEC |
| 2017 | $167 MSEC |
| 2016 | $128 MSEC |
| 2015 | $120 MSEC |
| 2014 | $106 MSEC |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| Net income | $-69 M |
|---|
| Employees | 785 |
|---|
| Valuation | |
|---|---|
| Price to sales | 2.3× |
| Price to book | 0.8× |
| Free cash flow yield | -20.3% |
| Profitability | |
|---|---|
| Gross margin | 41.9% |
| Operating margin | -62.6% |
| Net margin | -59.8% |
| Return on equity | -18.3% |
| Growth | |
|---|---|
| Revenue growth | -38.1% |
| Revenue growth, 3 years a year | -33.3% |
| Cash | |
|---|---|
| Free cash flow margin | -46.3% |
| Shareholder returns | |
|---|---|
| Shareholder yield | 5.7% |
| Altman Z-score zone | grey |
|---|
| Data as of | Market cap Oct 2026; ratios FY2025 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.